Trade Offs In Vaccine Development - Infectious Diseases

Relevant Publications

A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.

Issue Release: 2024

Vaccine decision making in New Zealand: a discrete choice experiment.

Issue Release: 2024

Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19.

Issue Release: 2023

The Brighton collaboration standardized module for vaccine benefit-risk assessment.

Issue Release: 2023

Humoral and T-cell-mediated responses to a pre-clinical Zika vaccine candidate that utilizes a unique insect-specific flavivirus platform.

Issue Release: 2023

Errors in Converting Principles to Protocols: Where the Bioethics of U.S. Covid-19 Vaccine Allocation Went Wrong.

Issue Release: 2022

Regional industrial growth and biopharma patent networks: empirical insights from the UK.

Issue Release: 2022

Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.

Issue Release: 2021

Designing transmissible viral vaccines for evolutionary robustness and maximum efficiency.

Issue Release: 2021

Enemy of My Enemy: A Novel Insect-Specific Flavivirus Offers a Promising Platform for a Zika Virus Vaccine.

Issue Release: 2021

Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis.

Issue Release: 2021

Early prediction of antigenic transitions for influenza A/H3N2.

Issue Release: 2020

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.

Issue Release: 2020

Graph-theoretical formulation of the generalized epitope-based vaccine design problem.

Issue Release: 2020

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making.

Issue Release: 2020

Operational analysis of school-based delivery models to vaccinate children against influenza.

Issue Release: 2020

Characterization of a Novel Orthomyxo-like Virus Causing Mass Die-Offs of Tilapia.

Issue Release: 2016

Vaccines: from valuation to resource allocation.

Issue Release: 2015

Factors affecting the levels of protection transferred from mother to offspring following immune challenge.

Issue Release: 2014

Cost-effectiveness analysis: should it be required for drug registration and beyond?

Issue Release: 2007

What are Antivirals?

How are Adenovirus Infections Diagnosed?

How is Efficacy Measured?

What are Commonly Used ACTs?

What are the Symptoms of Dengue?

What Diseases are Transmitted by Aedes Albopictus?

What Are the Common Symptoms of Infectious Diseases?

How Does Inflammation Help in Fighting Infections?

What Are the Treatment Options for Infected Newborns?

What are the Causes?

Partnered Content Networks

Relevant Topics